Page last updated: 2024-11-06

hydroxyproline and Diffuse Cutaneous Systemic Sclerosis

hydroxyproline has been researched along with Diffuse Cutaneous Systemic Sclerosis in 2 studies

Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
NELLAS, CL1
CRAWFORD, N1
SCHERBEL, AL1
Chan, ES1
Fernandez, P1
Merchant, AA1
Montesinos, MC1
Trzaska, S1
Desai, A1
Tung, CF1
Khoa, DN1
Pillinger, MH1
Reiss, AB1
Tomic-Canic, M1
Chen, JF1
Schwarzschild, MA1
Cronstein, BN1

Other Studies

2 other studies available for hydroxyproline and Diffuse Cutaneous Systemic Sclerosis

ArticleYear
PANCREATIC COLLAGENASE THERAPY FOR SEVERE, PROGRESSIVE SYSTEMIC SCLEROSIS. EFFECT ON SKIN AND ON HYDROXYPROLINE CONTENT IN URINE.
    Clinical pharmacology and therapeutics, 1965, Volume: 6

    Topics: Antibodies; Biopsy; Clinical Laboratory Techniques; Collagenases; Drug Therapy; Endopeptidases; Huma

1965
Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma.
    Arthritis and rheumatism, 2006, Volume: 54, Issue:8

    Topics: Animals; Cells, Cultured; Collagen; Dermis; Disease Models, Animal; Enzyme Inhibitors; Fibroblasts;

2006